Craig I Coleman Selected Research

Rivaroxaban

1/2022	Worsening of kidney function in patients with atrial fibrillation and chronic kidney disease: evidence from the real-world CALLIPER study.
1/2022	Combination anticoagulant or P2Y12 inhibitor with low-dose aspirin versus low-dose aspirin alone in patients at risk or with documented coronary and/or peripheral artery disease.
1/2022	Andexanet alfa versus four-factor prothrombin complex concentrate for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhage: a propensity score-overlap weighted analysis.
1/2022	Adherence and persistence to rivaroxaban in non-valvular atrial fibrillation patients receiving 30- or 90-day supply prescription fills.
2/2021	Effectiveness and safety of rivaroxaban versus warfarin in obese patients with acute venous thromboembolism: analysis of electronic health record data.
1/2021	Thromboembolism, bleeding and vascular death in nonvalvular atrial fibrillation patients with type 2 diabetes receiving rivaroxaban or warfarin.
1/2021	Kidney, limb and ophthalmic complications, and death in patients with nonvalvular atrial fibrillation and type 2 diabetes prescribed rivaroxaban or warfarin: an electronic health record analysis.
10/2020	Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes.
8/2020	Rivaroxaban Versus Warfarin in African American Patients with Nonvalvular Atrial Fibrillation.
4/2020	Rivaroxaban versus apixaban in non-valvular atrial fibrillation patients with end-stage renal disease or receiving dialysis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Craig I Coleman Research Topics

Disease

82	Atrial Fibrillation 01/2022 - 01/2004
56	Hemorrhage 01/2022 - 01/2006
34	Stroke (Strokes) 01/2022 - 03/2005
33	Venous Thromboembolism 02/2021 - 05/2012
18	Pulmonary Embolism 01/2019 - 05/2012
18	Heart Failure 01/2019 - 08/2003
16	Ischemic Stroke 01/2022 - 04/2012
15	Type 2 Diabetes Mellitus (MODY) 01/2021 - 09/2005
14	Embolism (Embolus) 01/2021 - 01/2012
11	Myocardial Infarction 05/2020 - 07/2005
10	Neoplasms (Cancer) 10/2020 - 01/2006
10	Venous Thrombosis (Deep-Vein Thrombosis) 01/2018 - 05/2012
8	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2022 - 01/2012
6	Ventricular Tachycardia 01/2020 - 04/2006
6	Hypertension (High Blood Pressure) 05/2016 - 09/2005
5	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 09/2005
5	Inflammation (Inflammations) 10/2020 - 04/2007
5	Coronary Disease (Coronary Heart Disease) 12/2018 - 01/2007
5	Diabetes Mellitus 01/2010 - 04/2004
4	Stable Angina 12/2018 - 03/2014
4	Weight Gain 01/2015 - 04/2010
4	Cardiomyopathies (Cardiomyopathy) 08/2013 - 04/2008
4	Chronic Obstructive Pulmonary Disease (COPD) 08/2009 - 03/2007
3	Chronic Renal Insufficiency 01/2022 - 01/2019
3	Peripheral Arterial Disease 01/2022 - 07/2005
3	Thromboembolism 01/2021 - 09/2016
3	Pain (Aches) 03/2020 - 01/2016
3	Hypotension (Low Blood Pressure) 03/2020 - 05/2006
3	Ventricular Fibrillation 01/2020 - 01/2012
3	Thrombosis (Thrombus) 01/2020 - 01/2013
3	Weight Loss (Weight Reduction) 01/2019 - 01/2004
3	Cardiac Sudden Death (Sudden Cardiac Arrest) 05/2018 - 07/2013
3	Cardiovascular Diseases (Cardiovascular Disease) 10/2016 - 01/2006
3	Shock 01/2015 - 06/2010
3	Magnesium Deficiency (Deficiency, Magnesium) 01/2015 - 04/2006
3	Body Weight (Weight, Body) 10/2010 - 10/2008
3	Insulin Resistance 10/2010 - 09/2005
3	Torsades de Pointes (Torsade de Pointes) 07/2009 - 04/2004
2	Dizziness (Lightheadedness) 03/2020 - 05/2009
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2020 - 12/2009
2	Wounds and Injuries (Trauma) 01/2019 - 08/2007
2	Asthma (Bronchial Asthma) 10/2018 - 10/2018
2	Frailty 01/2018 - 01/2018
2	Transient Ischemic Attack 01/2017 - 06/2011
2	Knee Osteoarthritis 01/2016 - 01/2016

Drug/Important Bio-Agent (IBA)

63	RivaroxabanIBA 01/2022 - 09/2012
48	Warfarin (Coumadin)FDA LinkGeneric 01/2022 - 04/2009
26	AnticoagulantsIBA 01/2022 - 09/2012
18	Vitamin K FDA Link 11/2019 - 04/2009
13	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2012 - 01/2006
12	apixabanIBA 01/2022 - 01/2012
12	Amiodarone (Amiodarona)FDA LinkGeneric 04/2008 - 04/2004
8	Factor Xa InhibitorsIBA 11/2020 - 09/2012
8	MagnesiumIBA 01/2015 - 01/2004
7	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2018 - 04/2007
6	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 04/2012
6	Glucose (Dextrose)FDA LinkGeneric 01/2015 - 09/2005
6	Pharmaceutical PreparationsIBA 01/2014 - 04/2004
6	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2009 - 09/2005
6	Angiotensin Receptor AntagonistsIBA 12/2009 - 09/2005
6	Digoxin (Digitek)FDA LinkGeneric 03/2007 - 03/2005
5	omega-Chloroacetophenone (Mace)IBA 01/2022 - 07/2006
5	Dabigatran FDA Link 01/2018 - 01/2015
4	Factor Xa (Coagulation Factor Xa)IBA 01/2022 - 09/2012
4	Ranolazine FDA Link 12/2018 - 03/2014
4	Enoxaparin (Lovenox)FDA LinkGeneric 01/2018 - 01/2014
4	CholesterolIBA 09/2013 - 01/2006
4	LipidsIBA 05/2010 - 01/2008
4	ibutilide (Corvert)FDA LinkGeneric 07/2009 - 01/2004
3	Prothrombin (Factor II)IBA 01/2022 - 11/2020
3	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2020 - 01/2014
3	N(4)-oleylcytosine arabinosideIBA 08/2019 - 09/2016
3	CanagliflozinIBA 01/2019 - 01/2018
3	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2019 - 04/2010
3	Hypoglycemic Agents (Hypoglycemics)IBA 01/2015 - 04/2010
3	Metformin (Glucophage)FDA LinkGeneric 01/2015 - 04/2010
3	Triglycerides (Triacylglycerol)IBA 09/2013 - 10/2008
3	Phytosterols (Plant Sterols)IBA 05/2010 - 11/2002
3	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 12/2009 - 01/2006
3	Dopamine Agonists (Dopamine Agonist)IBA 05/2009 - 05/2008
3	Aprotinin (Trasylol)FDA Link 06/2007 - 08/2004
2	PRT064445IBA 01/2022 - 01/2021
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 03/2020 - 04/2008
2	empagliflozinIBA 01/2018 - 01/2015
2	Indicators and Reagents (Reagents)IBA 01/2018 - 01/2018
2	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2018 - 01/2006
2	Heparin (Liquaemin)FDA LinkGeneric 10/2016 - 09/2012

Therapy/Procedure

46	Therapeutics 01/2022 - 09/2002
25	Length of Stay 01/2021 - 12/2004
5	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2014 - 04/2008
5	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 05/2013 - 04/2004
4	Injections 01/2020 - 01/2012
4	Secondary Prevention 01/2018 - 04/2008
3	Catheter Ablation 01/2020 - 03/2007
3	Contraindications 05/2016 - 02/2012
3	Blood Transfusion (Blood Transfusions) 02/2009 - 03/2007
3	Cardiopulmonary Bypass (Heart-Lung Bypass) 08/2007 - 07/2005
2	Renal Dialysis (Hemodialysis) 01/2019 - 01/2019
2	Defibrillators (Defibrillator) 05/2018 - 07/2013
2	Drug Therapy (Chemotherapy) 12/2017 - 04/2010